theophylline has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakura, M; Asano, Y; Asanuma, H; Ihara, M; Kato, H; Kitakaze, M; Minamino, T; Mochizuki, N; Mori, H; Shinozaki, Y; Sugimachi, M; Yamazaki, S | 1 |
| Aetesam-Ur-Rahman, M; Bennett, MR; Braganza, DM; Clarke, SC; Clarke, SJ; Giblett, JP; Hoole, SP; Khialani, B; Kyranis, S; West, NEJ; Zhao, TX | 1 |
2 other study(ies) available for theophylline and glucagon-like peptide 1
| Article | Year |
|---|---|
An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Topics: Adenosine; Adenosine Deaminase; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dogs; Extracellular Signal-Regulated MAP Kinases; Female; Glucagon-Like Peptide 1; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Myocardial Reperfusion Injury; Piperidines; Protein Binding; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Antagonists; Theophylline; Uracil | 2015 |
GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated.
Topics: Adenosine; Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Vessels; Female; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Signal Transduction; Theophylline; Vasodilation; Vasodilator Agents | 2021 |